aldosterone has been researched along with Apparent Mineralocorticoid Excess Syndrome in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Diagnosis relies on a triad of hypertension, hypokalemia and suppressed plasma aldosterone levels, plus an abnormal urinary cortisol to cortisone ratio, either free steroid or metabolites." | 4.95 | Apparent mineralocorticoid excess. ( Funder, JW, 2017) |
| "Spironolactone was initiated." | 1.72 | Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child. ( Baltu, D; Çelik Ertaş, NB; Duzova, A; Gönç, N; Gulhan, B; Ozcan, HN; Özdemir, G; Ünsal, Y; Utine, E, 2022) |
| "Primary aldosteronism (PA) and nonclassic apparent mineralocorticoid excess (NCAME) have been recognized as endocrine-related conditions having a broad clinical-biochemical spectrum, spanning from normotension to severe arterial hypertension (AHT)." | 1.72 | Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess. ( Carvajal, CA; Fardella, CE; Pérez, JA; Tapia-Castillo, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulhan, B | 1 |
| Ünsal, Y | 1 |
| Baltu, D | 1 |
| Çelik Ertaş, NB | 1 |
| Özdemir, G | 1 |
| Utine, E | 1 |
| Ozcan, HN | 1 |
| Duzova, A | 1 |
| Gönç, N | 1 |
| Tapia-Castillo, A | 1 |
| Carvajal, CA | 1 |
| Pérez, JA | 1 |
| Fardella, CE | 1 |
| Charoensri, S | 1 |
| Auchus, RJ | 1 |
| Kucuk, N | 1 |
| Yavas Abalı, Z | 1 |
| Abalı, S | 1 |
| Canpolat, N | 1 |
| Yesil, G | 1 |
| Turan, S | 1 |
| Bereket, A | 1 |
| Guran, T | 1 |
| Pandher, R | 1 |
| Puvanendran, A | 1 |
| Diamond, TH | 1 |
| Funder, JW | 1 |
| Miettinen, HE | 1 |
| Piippo, K | 1 |
| Hannila-Handelberg, T | 1 |
| Paukku, K | 1 |
| Hiltunen, TP | 1 |
| Gautschi, I | 1 |
| Schild, L | 1 |
| Kontula, K | 1 |
| Inagaki, K | 1 |
| Otsuka, F | 1 |
| Otani, H | 1 |
| Sato, C | 1 |
| Miyoshi, T | 1 |
| Ogura, T | 1 |
| Makino, H | 1 |
| Inada, M | 2 |
| Iwasaki, K | 1 |
| Imai, C | 1 |
| Hashimoto, S | 1 |
2 reviews available for aldosterone and Apparent Mineralocorticoid Excess Syndrome
| Article | Year |
|---|---|
Therapeutic management of congenital forms of endocrine hypertension.
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocort | 2023 |
Apparent mineralocorticoid excess.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Antihypertensive Agents; Cortisone; Diagno | 2017 |
Apparent mineralocorticoid excess.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Antihypertensive Agents; Cortisone; Diagno | 2017 |
Apparent mineralocorticoid excess.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Antihypertensive Agents; Cortisone; Diagno | 2017 |
Apparent mineralocorticoid excess.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Antihypertensive Agents; Cortisone; Diagno | 2017 |
8 other studies available for aldosterone and Apparent Mineralocorticoid Excess Syndrome
| Article | Year |
|---|---|
Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child.
Topics: Aldosterone; Amiloride; Blood Pressure; Child, Preschool; Female; Humans; Hypertension; Hypokalemia; | 2022 |
Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child.
Topics: Aldosterone; Amiloride; Blood Pressure; Child, Preschool; Female; Humans; Hypertension; Hypokalemia; | 2022 |
Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child.
Topics: Aldosterone; Amiloride; Blood Pressure; Child, Preschool; Female; Humans; Hypertension; Hypokalemia; | 2022 |
Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child.
Topics: Aldosterone; Amiloride; Blood Pressure; Child, Preschool; Female; Humans; Hypertension; Hypokalemia; | 2022 |
Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Topics: Aldosterone; Cortisone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Lipocalin | 2022 |
Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Topics: Aldosterone; Cortisone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Lipocalin | 2022 |
Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Topics: Aldosterone; Cortisone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Lipocalin | 2022 |
Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Topics: Aldosterone; Cortisone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Lipocalin | 2022 |
A rare cause of hypertension in childhood: Answers.
Topics: Aldosterone; Alkalosis; Bartter Syndrome; Child; Child, Preschool; Consanguinity; Cortisone; Diagnos | 2020 |
A rare cause of hypertension in childhood: Answers.
Topics: Aldosterone; Alkalosis; Bartter Syndrome; Child; Child, Preschool; Consanguinity; Cortisone; Diagnos | 2020 |
A rare cause of hypertension in childhood: Answers.
Topics: Aldosterone; Alkalosis; Bartter Syndrome; Child; Child, Preschool; Consanguinity; Cortisone; Diagnos | 2020 |
A rare cause of hypertension in childhood: Answers.
Topics: Aldosterone; Alkalosis; Bartter Syndrome; Child; Child, Preschool; Consanguinity; Cortisone; Diagnos | 2020 |
The dangers of herbal teas: hypertension and weakness caused by liquorice-induced apparent mineralocorticoid excess.
Topics: Aldosterone; Alkalosis; Female; Glycyrrhiza; Humans; Hypertension; Hypokalemia; Middle Aged; Mineral | 2020 |
The dangers of herbal teas: hypertension and weakness caused by liquorice-induced apparent mineralocorticoid excess.
Topics: Aldosterone; Alkalosis; Female; Glycyrrhiza; Humans; Hypertension; Hypokalemia; Middle Aged; Mineral | 2020 |
The dangers of herbal teas: hypertension and weakness caused by liquorice-induced apparent mineralocorticoid excess.
Topics: Aldosterone; Alkalosis; Female; Glycyrrhiza; Humans; Hypertension; Hypokalemia; Middle Aged; Mineral | 2020 |
The dangers of herbal teas: hypertension and weakness caused by liquorice-induced apparent mineralocorticoid excess.
Topics: Aldosterone; Alkalosis; Female; Glycyrrhiza; Humans; Hypertension; Hypokalemia; Middle Aged; Mineral | 2020 |
Licorice-induced hypertension and common variants of genes regulating renal sodium reabsorption.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adolescent; Adult; Aldosterone; Epithelial Sodium Chann | 2010 |
Apparent mineralocorticoid excess manifested in an elderly patient with hypothyroidism.
Topics: Aged, 80 and over; Aldosterone; Female; Humans; Hypertension; Hypokalemia; Hypothyroidism; Mineraloc | 2007 |
[A 87-year-old woman with mineralocorticoid excess due to 11 beta-HSD2 deficiency].
Topics: Aged, 80 and over; Aldosterone; Female; Glycyrrhiza; Humans; Mineralocorticoid Excess Syndrome, Appa | 2007 |
Two elderly patients with mineralocorticoid excess due to 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) impairment.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aged; Aged, 80 and over; Aldosterone; Female; Humans; M | 2008 |